Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial

被引:7
作者
Hanna, Catherine R. [1 ,2 ,3 ]
Blyth, Kevin G. [2 ,3 ]
Burley, Glenn [4 ]
Carmichael, Samantha [2 ]
Evans, Carol [1 ]
Hinsley, Samantha [1 ]
Khadra, Ibrahim [4 ]
Khoo, Saye [5 ]
Lewsley, Liz-Anne [1 ]
Jones, Robert R. [2 ,3 ]
Sharma, Raman [6 ]
Taladriz-Sender, Andrea [4 ]
Thomson, Emma C. [7 ]
Scott, Janet T. [2 ,7 ]
机构
[1] Univ Glasgow, CRUK Clin Trials Unit, Glasgow, Lanark, Scotland
[2] NHS Greater & Glasgow Clyde, Glasgow, Lanark, Scotland
[3] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland
[4] Univ Strathclyde, Glasgow, Lanark, Scotland
[5] Univ Liverpool, Dept Pharmacol, Liverpool, Merseyside, England
[6] Univ Liverpool Liverpool Sch Trop Med, Dept Trop Dis Biol, Liverpool, Merseyside, England
[7] Univ Glasgow, Inst Infect Immun & Inflammat, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland
关键词
COVID-19; Randomised controlled trial; protocol; favipiravir; inpatient; outpatient; early; pharmacokinetics; safety; tolerability; antiviral;
D O I
10.1186/s13063-020-04891-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial
    Nikhil Vergis
    Rachel Phillips
    Victoria Cornelius
    Alexia Katsarou
    Taryn Youngstein
    Lucy Cook
    Michelle Willicombe
    Clio Pilay
    Tina Shturova
    Melanie Almonte
    Asad Charania
    Richard Turner
    Onn Min Kon
    Graham Cooke
    Mark Thursz
    Svetlana Cherlin
    James Wason
    Dragana Milojkovic
    Andew J. Innes
    Nichola Cooper
    Trials, 22
  • [42] Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial
    Vergis, Nikhil
    Phillips, Rachel
    Cornelius, Victoria
    Katsarou, Alexia
    Youngstein, Taryn
    Cook, Lucy
    Willicombe, Michelle
    Pilay, Clio
    Shturova, Tina
    Almonte, Melanie
    Charania, Asad
    Turner, Richard
    Kon, Onn Min
    Cooke, Graham
    Thursz, Mark
    Cherlin, Svetlana
    Wason, James
    Milojkovic, Dragana
    Innes, Andew J.
    Cooper, Nichola
    TRIALS, 2021, 22 (01)
  • [43] Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial
    Pradeesh Sivapalan
    Charlotte Suppli Ulrik
    Rasmus Dahlin Bojesen
    Therese Sophie Lapperre
    Josefin Viktoria Eklöf
    Kjell Erik Julius Håkansson
    Andrea Browatzki
    Casper Tidemansen
    Jon Torgny Wilcke
    Julie Janner
    Vibeke Gottlieb
    Howraman Meteran
    Celeste Porsbjerg
    Birgitte Lindegaard Madsen
    Mia Moberg
    Lars Pedersen
    Thomas Lars Benfield
    Jens Dilling Lundgren
    Filip Krag Knop
    Tor Biering-Sørensen
    Muzhda Ghanizada
    Tine Peick Sonne
    Uffe Christian Steinholtz Bødtger
    Sidse Graff Jensen
    Daniel Bech Rasmussen
    Eva Brøndum
    Oliver Djurhuus Tupper
    Susanne Wiemann Sørensen
    Gitte Alstrup
    Christian Borbjerg Laursen
    Ulla Weinrich Møller
    Asger Sverrild
    Jens-Ulrik Stæhr Jensen
    Trials, 21
  • [44] Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial
    Sivapalan, Pradeesh
    Ulrik, Charlotte Suppli
    Bojesen, Rasmus Dahlin
    Lapperre, Therese Sophie
    Eklof, Josefin Viktoria
    Hakansson, Kjell Erik Julius
    Browatzki, Andrea
    Tidemansen, Casper
    Wilcke, Jon Torgny
    Janner, Julie
    Gottlieb, Vibeke
    Meteran, Howraman
    Porsbjerg, Celeste
    Madsen, Birgitte Lindegaard
    Moberg, Mia
    Pedersen, Lars
    Benfield, Thomas Lars
    Lundgren, Jens Dilling
    Knop, Filip Krag
    Biering-Sorensen, Tor
    Ghanizada, Muzhda
    Sonne, Tine Peick
    Bodtger, Uffe Christian Steinholtz
    Jensen, Sidse Graff
    Rasmussen, Daniel Bech
    Brondum, Eva
    Tupper, Oliver Djurhuus
    Sorensen, Susanne Wiemann
    Alstrup, Gitte
    Laursen, Christian Borbjerg
    Moller, Ulla Weinrich
    Sverrild, Asger
    Jensen, Jens-Ulrik Staehr
    TRIALS, 2020, 21 (01)
  • [45] Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial
    José Meneses Calderón
    Hugo Mendieta Zerón
    Srivatsan Padmanabhan
    Trials, 21
  • [46] Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial
    Olagunju, Adeniyi
    Fowotade, Adeola
    Olagunoye, Ajibola
    Ojo, Temitope Olumuyiwa
    Adefuye, Bolanle Olufunlola
    Fagbamigbe, Adeniyi Francis
    Adebiyi, Akindele Olupelumi
    Olagunju, Omobolanle Ibitayo
    Ladipo, Olabode Taiwo
    Akinloye, Abdulafeez
    Adeagbo, Babatunde Ayodeji
    Onayade, Adedeji
    Bolaji, Oluseye Oladotun
    Happi, Christian
    Rannard, Steve
    Owen, Andrew
    TRIALS, 2021, 22 (01)
  • [47] Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial
    Adeniyi Olagunju
    Adeola Fowotade
    Ajibola Olagunoye
    Temitope Olumuyiwa Ojo
    Bolanle Olufunlola Adefuye
    Adeniyi Francis Fagbamigbe
    Akindele Olupelumi Adebiyi
    Omobolanle Ibitayo Olagunju
    Olabode Taiwo Ladipo
    Abdulafeez Akinloye
    Babatunde Ayodeji Adeagbo
    Adedeji Onayade
    Oluseye Oladotun Bolaji
    Christian Happi
    Steve Rannard
    Andrew Owen
    Trials, 22
  • [48] Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial
    Abdulrahman E. Koshak
    Emad A. Koshak
    Abdullah F. Mobeireek
    Mazen A. Badawi
    Siraj O. Wali
    Husam M. Malibary
    Ali F. Atwah
    Meshari M. Alhamdan
    Reem A. Almalki
    Tariq A. Madani
    Trials, 21
  • [49] Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial
    Reihaneh Pirjani
    Tahereh Soori
    Ahmad Reza Dehpour
    Mahdi Sepidarkish
    Ashraf Moini
    Arshia Shizarpour
    Razieh Mohammad Jafari
    Trials, 21
  • [50] Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
    Hamid Reza Samimagham
    Mehdi Hassani Azad
    Dariush Hooshyar
    Maryam Haddad
    Mohsen Arabi
    Mitra KazemiJahromi
    Trials, 22